speb/financial-data huggingface dataset:
APLI.TO balance_sheet (annual, 2023-03-31) — Cash Financial: 2465882.00
APLI.TO cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 5908416.00
APLI.TO cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -3175.00
APLI.TO cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -10097836.00
APLI.TO cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -4158329.00
APLI.TO cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: -47553.00
APLI.TO cash_flow (annual, 2023-03-31) — Change In Receivables: 970294.00
APLI.TO cash_flow (annual, 2023-03-31) — Change In Working Capital: -3235588.00
APLI.TO cash_flow (annual, 2023-03-31) — Changes In Account Receivables: 346694.00
APLI.TO cash_flow (annual, 2023-03-31) — Changes In Cash: -4192595.00
APLI.TO balance_sheet (annual, 2023-03-31) — Common Stock: 42323359.00
APLI.TO balance_sheet (annual, 2023-03-31) — Common Stock Equity: -7396979.00
APLI.TO cash_flow (annual, 2023-03-31) — Common Stock Issuance: 3214286.00
APLI.TO balance_sheet (annual, 2023-03-31) — Current Assets: 3117765.00
APLI.TO balance_sheet (annual, 2023-03-31) — Current Debt: 113125.00
APLI.TO balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 113125.00
APLI.TO balance_sheet (annual, 2023-03-31) — Current Liabilities: 2977134.00
APLI.TO cash_flow (annual, 2023-03-31) — Depreciation: 6266.00
APLI.TO cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 6266.00
APLI.TO cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 6266.00
APLI.TO income_statement (annual, 2023-03-31) — Diluted Average Shares: 113731873.00
APLI.TO income_statement (annual, 2023-03-31) — Diluted EPS: -0.08
APLI.TO income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -9243014.00
APLI.TO income_statement (annual, 2023-03-31) — EBIT: -8110539.00
APLI.TO income_statement (annual, 2023-03-31) — EBITDA: -8104273.00
APLI.TO cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -6378.00
APLI.TO cash_flow (annual, 2023-03-31) — End Cash Position: 2465882.00
APLI.TO cash_flow (annual, 2023-03-31) — Financing Cash Flow: 5908416.00
APLI.TO cash_flow (annual, 2023-03-31) — Free Cash Flow: -10101011.00
APLI.TO cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 24546.00
APLI.TO income_statement (annual, 2023-03-31) — Gain On Sale Of Security: -364606.00
APLI.TO income_statement (annual, 2023-03-31) — General And Administrative Expense: 4438750.00
APLI.TO balance_sheet (annual, 2023-03-31) — Gross PPE: 55547.00
APLI.TO cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 12417.00
APLI.TO income_statement (annual, 2023-03-31) — Interest Expense: 1096083.00
APLI.TO income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1096083.00
APLI.TO income_statement (annual, 2023-03-31) — Interest Income: 29882.00
APLI.TO income_statement (annual, 2023-03-31) — Interest Income Non Operating: 29882.00
APLI.TO cash_flow (annual, 2023-03-31) — Interest Paid Cff: -83377.00
APLI.TO cash_flow (annual, 2023-03-31) — Interest Paid Supplemental Data: 476267.00
APLI.TO balance_sheet (annual, 2023-03-31) — Invested Capital: 268366.00
APLI.TO cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3175.00
APLI.TO cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 3214286.00
APLI.TO cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2500000.00
APLI.TO balance_sheet (annual, 2023-03-31) — Long Term Debt: 7552220.00
APLI.TO balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 7552220.00
APLI.TO cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2500000.00
APLI.TO cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -85600.00
APLI.TO balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 40525.00
APLI.TO cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 3214286.00
APLI.TO balance_sheet (annual, 2023-03-31) — Net Debt: 5199463.00
APLI.TO cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 378747.00
APLI.TO income_statement (annual, 2023-03-31) — Net Income: -9243014.00
APLI.TO income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -9243014.00
APLI.TO income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -9243014.00
APLI.TO income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -9243014.00
APLI.TO income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -9243014.00
APLI.TO cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -9243014.00
APLI.TO income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -9243014.00
APLI.TO income_statement (annual, 2023-03-31) — Net Interest Income: -1066201.00
APLI.TO cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
APLI.TO cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2414400.00
APLI.TO cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 2414400.00
APLI.TO income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1066201.00
APLI.TO cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -922607.00
APLI.TO balance_sheet (annual, 2023-03-31) — Net PPE: 14610.00
APLI.TO cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -3175.00
APLI.TO balance_sheet (annual, 2023-03-31) — Net Tangible Assets: -7396979.00
APLI.TO income_statement (annual, 2023-03-31) — Normalized EBITDA: -7739667.00
APLI.TO income_statement (annual, 2023-03-31) — Normalized Income: -9024250.40
APLI.TO cash_flow (annual, 2023-03-31) — Operating Cash Flow: -10097836.00
APLI.TO cash_flow (annual, 2023-03-31) — Operating Gains Losses: 403293.00
APLI.TO income_statement (annual, 2023-03-31) — Operating Income: -7775815.00
APLI.TO income_statement (annual, 2023-03-31) — Operating Revenue: 334177.00
APLI.TO balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 121266120.00
APLI.TO balance_sheet (annual, 2023-03-31) — Other Equity Interest: 9178905.00
APLI.TO income_statement (annual, 2023-03-31) — Other Gand A: 4438750.00
APLI.TO income_statement (annual, 2023-03-31) — Other Income Expense: -364606.00
APLI.TO cash_flow (annual, 2023-03-31) — Other Non Cash Items: 1096083.00
APLI.TO income_statement (annual, 2023-03-31) — Other Operating Expenses: 47373.00
APLI.TO balance_sheet (annual, 2023-03-31) — Other Properties: 15022.00
APLI.TO balance_sheet (annual, 2023-03-31) — Other Receivables: 69006.00
APLI.TO balance_sheet (annual, 2023-03-31) — Payables: 2864009.00
APLI.TO balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 2864009.00
APLI.TO balance_sheet (annual, 2023-03-31) — Prepaid Assets: 231099.00
APLI.TO income_statement (annual, 2023-03-31) — Pretax Income: -9206622.00
APLI.TO cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 1285714.00
APLI.TO cash_flow (annual, 2023-03-31) — Purchase Of PPE: -3175.00
APLI.TO balance_sheet (annual, 2023-03-31) — Receivables: 420784.00
APLI.TO income_statement (annual, 2023-03-31) — Reconciled Depreciation: 6266.00
APLI.TO cash_flow (annual, 2023-03-31) — Repayment Of Debt: -85600.00
APLI.TO income_statement (annual, 2023-03-31) — Research And Development: 3623869.00
APLI.TO balance_sheet (annual, 2023-03-31) — Retained Earnings: -65312206.00
APLI.TO cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
APLI.TO cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
APLI.TO income_statement (annual, 2023-03-31) — Selling General And Administration: 4438750.00
APLI.TO balance_sheet (annual, 2023-03-31) — Share Issued: 121266120.00
APLI.TO cash_flow (annual, 2023-03-31) — Stock Based Compensation: 875124.00
APLI.TO balance_sheet (annual, 2023-03-31) — Stockholders Equity: -7396979.00
APLI.TO balance_sheet (annual, 2023-03-31) — Tangible Book Value: -7396979.00
APLI.TO income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -145842.40
APLI.TO income_statement (annual, 2023-03-31) — Tax Provision: 36392.00
APLI.TO income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.40
APLI.TO balance_sheet (annual, 2023-03-31) — Taxes Receivable: 351778.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Assets: 3132375.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Capitalization: 155241.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Debt: 7665345.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: -7396979.00
APLI.TO income_statement (annual, 2023-03-31) — Total Expenses: 8109992.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 10529354.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 14610.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 7552220.00
APLI.TO balance_sheet (annual, 2023-03-31) — Total Tax Payable: 41008.00
APLI.TO income_statement (annual, 2023-03-31) — Total Unusual Items: -364606.00
APLI.TO income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -364606.00
APLI.TO balance_sheet (annual, 2023-03-31) — Working Capital: 140631.00
APLI.TO income_statement (annual, 2024-03-31) — +Operating Expense: 2990197.00
APLI.TO income_statement (annual, 2024-03-31) — +Total Revenue: 827407.00
APLI.TO balance_sheet (annual, 2024-03-31) — Accounts Payable: 4183176.00
APLI.TO balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -52695.00
APLI.TO balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 12869975.00
APLI.TO income_statement (annual, 2024-03-31) — Basic Average Shares: 121266120.00
APLI.TO income_statement (annual, 2024-03-31) — Basic EPS: -0.03
APLI.TO cash_flow (annual, 2024-03-31) — Beginning Cash Position: 2465882.00
APLI.TO cash_flow (annual, 2024-03-31) — Capital Expenditure: -29717.00
APLI.TO balance_sheet (annual, 2024-03-31) — Capital Stock: 42323359.00
APLI.TO balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 94493.00
APLI.TO balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 94493.00
APLI.TO cash_flow (annual, 2024-03-31) — Cash Dividends Paid: 0.00
APLI.TO balance_sheet (annual, 2024-03-31) — Cash Financial: 94493.00
APLI.TO cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 122045.00
APLI.TO cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -29063.00
APLI.TO cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: -2464425.00
APLI.TO cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 1375327.00
APLI.TO cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: 38666.00
APLI.TO cash_flow (annual, 2024-03-31) — Change In Receivables: -752551.00
APLI.TO cash_flow (annual, 2024-03-31) — Change In Working Capital: 661442.00
APLI.TO cash_flow (annual, 2024-03-31) — Changes In Account Receivables: -1038051.00
APLI.TO cash_flow (annual, 2024-03-31) — Changes In Cash: -2371443.00
APLI.TO balance_sheet (annual, 2024-03-31) — Common Stock: 42323359.00
APLI.TO balance_sheet (annual, 2024-03-31) — Common Stock Equity: -10924779.00
APLI.TO cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
APLI.TO balance_sheet (annual, 2024-03-31) — Current Assets: 1460261.00
APLI.TO balance_sheet (annual, 2024-03-31) — Current Debt: 7309657.00
APLI.TO balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 7309657.00
APLI.TO balance_sheet (annual, 2024-03-31) — Current Liabilities: 11539982.00
APLI.TO cash_flow (annual, 2024-03-31) — Depreciation: 13662.00
APLI.TO cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 13662.00
APLI.TO cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 13662.00
APLI.TO income_statement (annual, 2024-03-31) — Diluted Average Shares: 121266120.00
APLI.TO income_statement (annual, 2024-03-31) — Diluted EPS: -0.03
APLI.TO income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -3780910.00
APLI.TO income_statement (annual, 2024-03-31) — EBIT: -2080322.00
APLI.TO income_statement (annual, 2024-03-31) — EBITDA: -2066660.00
APLI.TO cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 54.00
APLI.TO cash_flow (annual, 2024-03-31) — End Cash Position: 94493.00
APLI.TO cash_flow (annual, 2024-03-31) — Financing Cash Flow: 122045.00
APLI.TO cash_flow (annual, 2024-03-31) — Free Cash Flow: -2494142.00
APLI.TO cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -131.00
APLI.TO income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 65656.00
APLI.TO income_statement (annual, 2024-03-31) — General And Administrative Expense: 3047135.00
APLI.TO balance_sheet (annual, 2024-03-31) — Gross PPE: 82837.00
APLI.TO cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 62601.00
APLI.TO income_statement (annual, 2024-03-31) — Interest Expense: 1631005.00
APLI.TO income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1631005.00
APLI.TO income_statement (annual, 2024-03-31) — Interest Income: 16812.00
APLI.TO income_statement (annual, 2024-03-31) — Interest Income Non Operating: 16812.00
APLI.TO cash_flow (annual, 2024-03-31) — Interest Paid Cff: -72521.00
APLI.TO cash_flow (annual, 2024-03-31) — Interest Paid Supplemental Data: 1103315.00
APLI.TO balance_sheet (annual, 2024-03-31) — Invested Capital: -2739922.00
APLI.TO cash_flow (annual, 2024-03-31) — Investing Cash Flow: -29063.00
APLI.TO cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
APLI.TO cash_flow (annual, 2024-03-31) — Issuance Of Debt: 300000.00
APLI.TO balance_sheet (annual, 2024-03-31) — Long Term Debt: 875200.00
APLI.TO balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 875200.00
APLI.TO cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 300000.00
APLI.TO cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -96423.00
APLI.TO balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 44969.00
APLI.TO cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
APLI.TO balance_sheet (annual, 2024-03-31) — Net Debt: 8090364.00
APLI.TO cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -35410.00
APLI.TO income_statement (annual, 2024-03-31) — Net Income: -3780910.00
APLI.TO income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -3780910.00
APLI.TO income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -3780910.00
APLI.TO income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -3780910.00
APLI.TO income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -3780910.00
APLI.TO cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -3780910.00
APLI.TO income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -3780910.00
APLI.TO income_statement (annual, 2024-03-31) — Net Interest Income: -1614193.00
APLI.TO cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 203577.00
APLI.TO cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 203577.00
APLI.TO income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -1614193.00
APLI.TO cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -9011.00
APLI.TO balance_sheet (annual, 2024-03-31) — Net PPE: 30142.00
APLI.TO cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -29063.00
APLI.TO balance_sheet (annual, 2024-03-31) — Net Tangible Assets: -10924779.00
APLI.TO income_statement (annual, 2024-03-31) — Normalized EBITDA: -2132316.00
APLI.TO income_statement (annual, 2024-03-31) — Normalized Income: -3836717.60
APLI.TO cash_flow (annual, 2024-03-31) — Operating Cash Flow: -2464425.00
APLI.TO cash_flow (annual, 2024-03-31) — Operating Gains Losses: -35541.00
APLI.TO income_statement (annual, 2024-03-31) — Operating Income: -2162790.00
APLI.TO income_statement (annual, 2024-03-31) — Operating Revenue: 827407.00
APLI.TO balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 121266120.00
APLI.TO balance_sheet (annual, 2024-03-31) — Other Equity Interest: 2975003.00
APLI.TO income_statement (annual, 2024-03-31) — Other Gand A: 3047135.00
APLI.TO income_statement (annual, 2024-03-31) — Other Income Expense: 65656.00
APLI.TO cash_flow (annual, 2024-03-31) — Other Non Cash Items: 485576.00
APLI.TO income_statement (annual, 2024-03-31) — Other Operating Expenses: -5679212.00
APLI.TO balance_sheet (annual, 2024-03-31) — Other Properties: 37868.00
APLI.TO balance_sheet (annual, 2024-03-31) — Other Receivables: 1086725.00
APLI.TO balance_sheet (annual, 2024-03-31) — Payables: 4230325.00
APLI.TO balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 4230325.00
APLI.TO balance_sheet (annual, 2024-03-31) — Prepaid Assets: 192433.00
APLI.TO income_statement (annual, 2024-03-31) — Pretax Income: -3711327.00
APLI.TO cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 0.00
APLI.TO cash_flow (annual, 2024-03-31) — Purchase Of PPE: -29717.00
APLI.TO balance_sheet (annual, 2024-03-31) — Receivables: 1173335.00
APLI.TO income_statement (annual, 2024-03-31) — Reconciled Depreciation: 13662.00
APLI.TO cash_flow (annual, 2024-03-31) — Repayment Of Debt: -96423.00
APLI.TO income_statement (annual, 2024-03-31) — Research And Development: 5622274.00
APLI.TO balance_sheet (annual, 2024-03-31) — Retained Earnings: -69093116.00
APLI.TO cash_flow (annual, 2024-03-31) — Sale Of PPE: 654.00
APLI.TO income_statement (annual, 2024-03-31) — Selling General And Administration: 3047135.00
APLI.TO balance_sheet (annual, 2024-03-31) — Share Issued: 121266120.00
APLI.TO cash_flow (annual, 2024-03-31) — Stock Based Compensation: 191346.00
APLI.TO balance_sheet (annual, 2024-03-31) — Stockholders Equity: -10924779.00
APLI.TO balance_sheet (annual, 2024-03-31) — Tangible Book Value: -10924779.00
APLI.TO income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 9848.40
APLI.TO income_statement (annual, 2024-03-31) — Tax Provision: 69583.00
APLI.TO income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.15
APLI.TO balance_sheet (annual, 2024-03-31) — Taxes Receivable: 86610.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Assets: 1490403.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Capitalization: -10049579.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Debt: 8184857.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: -10924779.00
APLI.TO income_statement (annual, 2024-03-31) — Total Expenses: 2990197.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 12415182.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 30142.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 875200.00
APLI.TO balance_sheet (annual, 2024-03-31) — Total Tax Payable: 47149.00
APLI.TO income_statement (annual, 2024-03-31) — Total Unusual Items: 65656.00
APLI.TO income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 65656.00
APLI.TO balance_sheet (annual, 2024-03-31) — Working Capital: -10079721.00
APLI.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.01
APLI.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.01
APLI.TO income_statement (quarterly, 2024-09-30) — Interest Expense: 530289.00
APLI.TO income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 530289.00
APLI.TO income_statement (quarterly, 2024-09-30) — Interest Income: 0.00
APLI.TO income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 0.00
APLI.TO cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 1033857.00
APLI.TO income_statement (quarterly, 2024-12-31) — +Operating Expense: -388713.00
APLI.TO income_statement (quarterly, 2024-12-31) — +Total Revenue: 108359.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 4434443.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 14816582.00
APLI.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 665219.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -702.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Capital Stock: 42323359.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 186166.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 186166.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Cash Financial: 186166.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -40562.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -702.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -442371.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 188692.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: -13082.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Change In Receivables: -1008801.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -833191.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -1024001.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Changes In Cash: -483635.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Common Stock: 42323359.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -13626879.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Current Assets: 2071414.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Current Debt: 10472854.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 10472854.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 14909143.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Depreciation: 4075.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 4075.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 4075.00
APLI.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.00
APLI.TO income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -524337.00
APLI.TO income_statement (quarterly, 2024-12-31) — EBIT: -12280.00
APLI.TO income_statement (quarterly, 2024-12-31) — EBITDA: -8205.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 4582.00
APLI.TO cash_flow (quarterly, 2024-12-31) — End Cash Position: 186166.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -40562.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -443073.00
APLI.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -509388.00
APLI.TO income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 443261.00
APLI.TO income_statement (quarterly, 2024-12-31) — Interest Expense: 522022.00
APLI.TO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 522022.00
APLI.TO income_statement (quarterly, 2024-12-31) — Interest Income: 36.00
APLI.TO income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 36.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Interest Paid Cff: -13006.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: -1004523.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Invested Capital: -2342625.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -702.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 811400.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 811400.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -27556.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Net Debt: 11098088.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 390406.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Income: -524337.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -524337.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -524337.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -524337.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -524337.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -524337.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -524337.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Interest Income: -521986.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -27556.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -27556.00
APLI.TO income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -521986.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Net PPE: 22250.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -702.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -13626879.00
APLI.TO income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 501183.00
APLI.TO income_statement (quarterly, 2024-12-31) — Normalized Income: -24449.34
APLI.TO cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -442371.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 390406.00
APLI.TO income_statement (quarterly, 2024-12-31) — Operating Income: 497072.00
APLI.TO income_statement (quarterly, 2024-12-31) — Operating Revenue: 108359.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 121266120.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 1179038.00
APLI.TO income_statement (quarterly, 2024-12-31) — Other Gand A: 443261.00
APLI.TO income_statement (quarterly, 2024-12-31) — Other Income Expense: -509388.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 507842.00
APLI.TO income_statement (quarterly, 2024-12-31) — Other Operating Expenses: -2553503.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 1668704.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Payables: 4436289.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 4436289.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 125772.00
APLI.TO income_statement (quarterly, 2024-12-31) — Pretax Income: -534302.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -702.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Receivables: 1759476.00
APLI.TO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 4075.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -27556.00
APLI.TO income_statement (quarterly, 2024-12-31) — Research And Development: 1721529.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -71945858.00
APLI.TO income_statement (quarterly, 2024-12-31) — Selling General And Administration: 443261.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Share Issued: 121266120.00
APLI.TO cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 12834.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -13626879.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -13626879.00
APLI.TO income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -9500.34
APLI.TO income_statement (quarterly, 2024-12-31) — Tax Provision: -9965.00
APLI.TO income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.02
APLI.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 90772.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Assets: 2093664.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -12815479.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Debt: 11284254.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -13626879.00
APLI.TO income_statement (quarterly, 2024-12-31) — Total Expenses: -388713.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 15720543.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 22250.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 811400.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1846.00
APLI.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: -509388.00
APLI.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -509388.00
APLI.TO balance_sheet (quarterly, 2024-12-31) — Working Capital: -12837729.00
APLI.TO income_statement (annual, 2025-03-31) — +Operating Expense: 291282.00
APLI.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 49197.00
APLI.TO income_statement (annual, 2025-03-31) — +Total Revenue: 100443.00
APLI.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: -12606.00
APLI.TO balance_sheet (annual, 2025-03-31) — Accounts Payable: 4106126.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4106126.00
APLI.TO balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 14818071.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 14818071.00
APLI.TO income_statement (annual, 2025-03-31) — Basic Average Shares: 121266120.00
APLI.TO income_statement (annual, 2025-03-31) — Basic EPS: -0.02
APLI.TO cash_flow (annual, 2025-03-31) — Beginning Cash Position: 94493.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 186166.00
APLI.TO cash_flow (annual, 2025-03-31) — Capital Expenditure: -2360.00
APLI.TO balance_sheet (annual, 2025-03-31) — Capital Stock: 42323359.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 42323359.00
APLI.TO balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1228244.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1228244.00
APLI.TO balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1228244.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1228244.00
APLI.TO cash_flow (annual, 2025-03-31) — Cash Dividends Paid: 0.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
APLI.TO balance_sheet (annual, 2025-03-31) — Cash Financial: 1228244.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1228244.00
APLI.TO cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 193683.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -61209.00
APLI.TO cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -2360.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
APLI.TO cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: 868816.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1034235.00
APLI.TO cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 193427.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -300692.00
APLI.TO cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: 77919.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 11258.00
APLI.TO cash_flow (annual, 2025-03-31) — Change In Receivables: -497538.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 88603.00
APLI.TO cash_flow (annual, 2025-03-31) — Change In Working Capital: -226192.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -200831.00
APLI.TO cash_flow (annual, 2025-03-31) — Changes In Account Receivables: -500338.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 91903.00
APLI.TO cash_flow (annual, 2025-03-31) — Changes In Cash: 1060139.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 973026.00
APLI.TO balance_sheet (annual, 2025-03-31) — Common Stock: 42323359.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 42323359.00
APLI.TO balance_sheet (annual, 2025-03-31) — Common Stock Equity: -13397340.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -13397340.00
APLI.TO cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
APLI.TO balance_sheet (annual, 2025-03-31) — Current Assets: 3013631.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 3013631.00
APLI.TO balance_sheet (annual, 2025-03-31) — Current Debt: 11558317.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 11558317.00
APLI.TO balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 11558317.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 11558317.00
APLI.TO balance_sheet (annual, 2025-03-31) — Current Liabilities: 15693914.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 15693914.00
APLI.TO cash_flow (annual, 2025-03-31) — Depreciation: 13460.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 3208.00
APLI.TO cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 13460.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3208.00
APLI.TO cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 13460.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3208.00
APLI.TO income_statement (annual, 2025-03-31) — Diluted Average Shares: 121266120.00
APLI.TO income_statement (annual, 2025-03-31) — Diluted EPS: -0.02
APLI.TO income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -2624692.00
APLI.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 228050.00
APLI.TO income_statement (annual, 2025-03-31) — EBIT: 347106.00
APLI.TO income_statement (quarterly, 2025-03-31) — EBIT: 925237.00
APLI.TO income_statement (annual, 2025-03-31) — EBITDA: 360566.00
APLI.TO income_statement (quarterly, 2025-03-31) — EBITDA: 928445.00
APLI.TO cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 73612.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 69052.00
APLI.TO cash_flow (annual, 2025-03-31) — End Cash Position: 1228244.00
APLI.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 1228244.00
APLI.TO cash_flow (annual, 2025-03-31) — Financing Cash Flow: 193683.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -61209.00
APLI.TO cash_flow (annual, 2025-03-31) — Free Cash Flow: 866456.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1034235.00
APLI.TO cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
APLI.TO income_statement (annual, 2025-03-31) — Gain On Sale Of Security: -329154.00
APLI.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 119977.00
APLI.TO income_statement (annual, 2025-03-31) — General And Administrative Expense: 2853211.00
APLI.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 991764.00
APLI.TO income_statement (annual, 2025-03-31) — Interest Expense: 2952968.00
APLI.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 669552.00
APLI.TO income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 2952968.00
APLI.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 669552.00
APLI.TO income_statement (annual, 2025-03-31) — Interest Income: 36.00
APLI.TO income_statement (quarterly, 2025-03-31) — Interest Income: 0.00
APLI.TO income_statement (annual, 2025-03-31) — Interest Income Non Operating: 36.00
APLI.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 0.00
APLI.TO cash_flow (annual, 2025-03-31) — Interest Paid Cff: -64501.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -16353.00
APLI.TO balance_sheet (annual, 2025-03-31) — Invested Capital: -1102923.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: -1102923.00
APLI.TO cash_flow (annual, 2025-03-31) — Investing Cash Flow: -2360.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
APLI.TO cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
APLI.TO cash_flow (annual, 2025-03-31) — Issuance Of Debt: 400000.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
APLI.TO balance_sheet (annual, 2025-03-31) — Long Term Debt: 736100.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 736100.00
APLI.TO balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 736100.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 736100.00
APLI.TO cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 400000.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
APLI.TO cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -141816.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -44856.00
APLI.TO cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
APLI.TO balance_sheet (annual, 2025-03-31) — Net Debt: 11066173.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 11066173.00
APLI.TO cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 170109.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -177013.00
APLI.TO income_statement (annual, 2025-03-31) — Net Income: -2624692.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Income: 228050.00
APLI.TO income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -2624692.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 228050.00
APLI.TO income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -2624692.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 228050.00
APLI.TO income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2624692.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 228050.00
APLI.TO income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2624692.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 228050.00
APLI.TO cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -2624692.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 228050.00
APLI.TO income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -2624692.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 228050.00
APLI.TO income_statement (annual, 2025-03-31) — Net Interest Income: -3500846.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -1217466.00
APLI.TO cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 258184.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -44856.00
APLI.TO cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 258184.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -44856.00
APLI.TO income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -3500846.00
APLI.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1217466.00
APLI.TO balance_sheet (annual, 2025-03-31) — Net PPE: 19043.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 19043.00
APLI.TO cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -2360.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
APLI.TO balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -13397340.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -13397340.00
APLI.TO income_statement (annual, 2025-03-31) — Normalized EBITDA: 689720.00
APLI.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 808468.00
APLI.TO income_statement (annual, 2025-03-31) — Normalized Income: -2344911.10
APLI.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 121040.38
APLI.TO cash_flow (annual, 2025-03-31) — Operating Cash Flow: 868816.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1034235.00
APLI.TO cash_flow (annual, 2025-03-31) — Operating Gains Losses: 170109.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -177013.00
APLI.TO income_statement (annual, 2025-03-31) — Operating Income: -190839.00
APLI.TO income_statement (quarterly, 2025-03-31) — Operating Income: -61803.00
APLI.TO income_statement (annual, 2025-03-31) — Operating Revenue: 100443.00
APLI.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: -12606.00
APLI.TO balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 121266120.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 121266120.00
APLI.TO balance_sheet (annual, 2025-03-31) — Other Equity Interest: 1179038.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1179038.00
APLI.TO income_statement (annual, 2025-03-31) — Other Gand A: 2853211.00
APLI.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 991764.00
APLI.TO income_statement (annual, 2025-03-31) — Other Income Expense: 1085823.00
APLI.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 1534954.00
APLI.TO cash_flow (annual, 2025-03-31) — Other Non Cash Items: 3418329.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1170133.00
APLI.TO income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1414977.00
APLI.TO income_statement (annual, 2025-03-31) — Other Operating Expenses: -9886387.00
APLI.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -2470769.00
APLI.TO balance_sheet (annual, 2025-03-31) — Other Receivables: 1599333.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1599333.00
APLI.TO balance_sheet (annual, 2025-03-31) — Payables: 4135597.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Payables: 4135597.00
APLI.TO balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 4135597.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 4135597.00
APLI.TO balance_sheet (annual, 2025-03-31) — Prepaid Assets: 114514.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 114514.00
APLI.TO income_statement (annual, 2025-03-31) — Pretax Income: -2605862.00
APLI.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 255685.00
APLI.TO cash_flow (annual, 2025-03-31) — Purchase Of PPE: -2360.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
APLI.TO balance_sheet (annual, 2025-03-31) — Receivables: 1670873.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 1670873.00
APLI.TO income_statement (annual, 2025-03-31) — Reconciled Depreciation: 13460.00
APLI.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3208.00
APLI.TO cash_flow (annual, 2025-03-31) — Repayment Of Debt: -141816.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -44856.00
APLI.TO income_statement (annual, 2025-03-31) — Research And Development: 7324458.00
APLI.TO income_statement (quarterly, 2025-03-31) — Research And Development: 1528202.00
APLI.TO balance_sheet (annual, 2025-03-31) — Retained Earnings: -71717808.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -71717808.00
APLI.TO cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
APLI.TO income_statement (annual, 2025-03-31) — Selling General And Administration: 2853211.00
APLI.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 991764.00
APLI.TO balance_sheet (annual, 2025-03-31) — Share Issued: 121266120.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 121266120.00
APLI.TO cash_flow (annual, 2025-03-31) — Stock Based Compensation: 117802.00
APLI.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 10688.00
APLI.TO balance_sheet (annual, 2025-03-31) — Stockholders Equity: -13397340.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -13397340.00
APLI.TO balance_sheet (annual, 2025-03-31) — Tangible Book Value: -13397340.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -13397340.00
APLI.TO income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -49373.10
APLI.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 12967.38
APLI.TO income_statement (annual, 2025-03-31) — Tax Provision: 18830.00
APLI.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 27635.00
APLI.TO income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.15
APLI.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.11
APLI.TO balance_sheet (annual, 2025-03-31) — Taxes Receivable: 71540.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 71540.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Assets: 3032674.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 3032674.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Capitalization: -12661240.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -12661240.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Debt: 12294417.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 12294417.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: -13397340.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -13397340.00
APLI.TO income_statement (annual, 2025-03-31) — Total Expenses: 291282.00
APLI.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 49197.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 16430014.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 16430014.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 19043.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 19043.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 736100.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 736100.00
APLI.TO income_statement (annual, 2025-03-31) — Total Other Finance Cost: 547914.00
APLI.TO balance_sheet (annual, 2025-03-31) — Total Tax Payable: 29471.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 29471.00
APLI.TO income_statement (annual, 2025-03-31) — Total Unusual Items: -329154.00
APLI.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 119977.00
APLI.TO income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -329154.00
APLI.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 119977.00
APLI.TO balance_sheet (annual, 2025-03-31) — Working Capital: -12680283.00
APLI.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: -12680283.00
APLI.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 1052556.00
APLI.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4161607.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 14836167.00
APLI.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 121266120.00
APLI.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.01
APLI.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1228244.00
APLI.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 42323359.00